jennster
New_Member
I'm not sure if anyone has seen this yet, but now they are trying to get sema removed from compounding. They're taking a different angle with the same intentions. Ozempic compounding
And yet, it is so very obviously not complex to compound. If the FDA allows the classification of Reta as a biologic, it seems they are full of it. From what I read, biological have to be derived from living cells and tissues and can’t by lyophilized in a lab, which we already know is absolutely possible.Trying to have FDA label it is as demonstrably complex to compound would prevent all compounding. This process usually takes 12-18 months, so not anytime soon.
Glad we have research peps!
On another note, Eli Lilly is thinking ahead with Retatrutide and already filed to have it labeled as a biological, this would also prevent compounding out of the gate when it goes retail in 2026.
It's all about making all the profits. But that is why they are in the drug business.
I assume having one component of CagriSema already on the demonstrably complex to compound list, should they succeed in getting it classified as such, would make it much easier to argue the same for future products that they release.Trying to have FDA label it is as demonstrably complex to compound would prevent all compounding. This process usually takes 12-18 months, so not anytime soon.
Glad we have research peps!
On another note, Eli Lilly is thinking ahead with Retatrutide and already filed to have it labeled as a biological, this would also prevent compounding out of the gate when it goes retail in 2026.
It's all about making all the profits. But that is why they are in the drug business.
And yet, it is so very obviously not complex to compound. If the FDA allows the classification of Reta as a biologic, it seems they are full of it. From what I read, biological have to be derived from living cells and tissues and can’t by lyophilized in a lab, which we already know is absolutely possible.
I doubt there's anything realistically they can do to stop ChinaI assume having one component of CagriSema already on the demonstrably complex to compound list, should they succeed in getting it classified as such, would make it much easier to argue the same for future products that they release.
Expect to see every trick in the book pulled out in an attempt to keep this cash cow, aka the American people, paying full price for all of their current and future products. Makes me wonder what lengths they will go to prevent people from using gray market products if enough people move over to them
I think they could place additional scrutiny on our end on stuff being imported in. At this point the researcher is glad to wait the extra time and have things sent to a US warehouse and then routed to them.I doubt there's anything realistically they can do to stop China